FDA Policy for REMS Reqmts during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the coronavirus pandemic public health emergency.
Read the Policy now
Related Education Resources.
All ResourcesGCSG Presentation Tips from Steve Jacobs
Topics: Communication, Personal Development
Conference Training
Members
Direct-to-Patient Survey Results Summary
Topics: Health Care, Innovation, Supply Chain
Report
Free
2023 US Conference - Sponsorship and Exhibitor Overview
Topic: Conference
Video
Free
